Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Chester

Showing results (251-260 of 264) with videos related to

Pageof 27
Sort By:
Cancer Immunology, Immunotherapy : CII|June 30, 2017
The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicityFiona C Thistlethwaite, David E Gilham, Ryan D Guest, et al.
Physical Review Letters|November 13, 2007
Z = 50 shell gap near 100Sn from intermediate-energy Coulomb excitations in even-mass 106-112Sn isotopesC Vaman, C Andreoiu, D Bazin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2009
A phase I trial of radioimmunotherapy with 131I-A5B7 anti-CEA antibody in combination with combretastatin-A4-phosphate in advanced gastrointestinal carcinomasTim Meyer, Andrew M Gaya, Gairin Dancey, et al.
Psychiatry and Clinical Neurosciences|April 18, 2023
Influence of cannabis use on incidence of psychosis in people at clinical high riskLucy A Chester, Lucia R Valmaggia, Matthew J Kempton, et al.
Physical Review Letters|August 7, 2007
Shape and structure of N=Z 64Ge: electromagnetic transition rates from the application of the recoil distance method to a knockout reactionK Starosta, A Dewald, A Dunomes, et al.
Immunity|April 16, 2017
Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established TumorsFrederick Arce Vargas, Andrew J S Furness, Isabelle Solomon, et al.
Mabs|December 31, 2015
The INNs and outs of antibody nonproprietary namesTim D Jones, Paul J Carter, Andreas Plückthun, et al.
Immunity|May 30, 2025
Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodiesFelipe Galvez-Cancino, Mariela Navarrete, Gordon Beattie, et al.
Immunity|April 25, 2025
Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodiesFelipe Galvez-Cancino, Mariela Navarrete, Gordon Beattie, et al.
Physical Review Letters|December 3, 2022
Crossing N=28 Toward the Neutron Drip Line: First Measurement of Half-Lives at FRIBH L Crawford, V Tripathi, J M Allmond, et al.
Pageof 27

Showing results (251-260 of 264) with videos related to

Sort By:
Pageof 27
Cancer Immunology, Immunotherapy : CII|June 30, 2017
The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicityFiona C Thistlethwaite, David E Gilham, Ryan D Guest, et al.
Physical Review Letters|November 13, 2007
Z = 50 shell gap near 100Sn from intermediate-energy Coulomb excitations in even-mass 106-112Sn isotopesC Vaman, C Andreoiu, D Bazin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2009
A phase I trial of radioimmunotherapy with 131I-A5B7 anti-CEA antibody in combination with combretastatin-A4-phosphate in advanced gastrointestinal carcinomasTim Meyer, Andrew M Gaya, Gairin Dancey, et al.
Psychiatry and Clinical Neurosciences|April 18, 2023
Influence of cannabis use on incidence of psychosis in people at clinical high riskLucy A Chester, Lucia R Valmaggia, Matthew J Kempton, et al.
Physical Review Letters|August 7, 2007
Shape and structure of N=Z 64Ge: electromagnetic transition rates from the application of the recoil distance method to a knockout reactionK Starosta, A Dewald, A Dunomes, et al.
Immunity|April 16, 2017
Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established TumorsFrederick Arce Vargas, Andrew J S Furness, Isabelle Solomon, et al.
Mabs|December 31, 2015
The INNs and outs of antibody nonproprietary namesTim D Jones, Paul J Carter, Andreas Plückthun, et al.
Immunity|May 30, 2025
Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodiesFelipe Galvez-Cancino, Mariela Navarrete, Gordon Beattie, et al.
Immunity|April 25, 2025
Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodiesFelipe Galvez-Cancino, Mariela Navarrete, Gordon Beattie, et al.
Physical Review Letters|December 3, 2022
Crossing N=28 Toward the Neutron Drip Line: First Measurement of Half-Lives at FRIBH L Crawford, V Tripathi, J M Allmond, et al.
Pageof 27